Skip to main content
. 2021 Sep 29;43(4):2531–2536. doi: 10.1007/s10072-021-05622-3

Table 1.

Demographic and clinical characteristics of PD patients. Values are shown as mean ± standard deviation

PD patients
n = 62
Age (yr) 71.40 ± 7.84
Education (yr) 11.26 ± 3.78
Gender (M:F) 36:26
MMSE score 28.46 ± 1.98
MCI (Y:N) 29:33
MDS-UPDRS-III score 20.76 ± 8.31
GDS-15 score 3.61 ± 3.10
PDSS-2 scores
  Total score 13.91 ± 9.47
  Abnormal total score (≥ 18) n = 16 (25.8%)
  Fragmented sleep 4.5 ± 2.45
  Insomnia symptoms 1.5 ± 1.79
  Motor symptoms 4.24 ± 4.62
  Dream distressing 1.06 ± 1.78
  Sleep quality 2.61 ± 2.11
Polysomnographic data
  SE (%) 79.42 ± 10.4
  Any-REM (%) 22.22 ± 44.09
  PSG-confirmed RBD n = 34 (54.83%)
  WASO (min) 96.88 ± 72.27
  SL (min) 40.28 ± 88.77
  Awakenings (n/TST) 0.06 ± 0.04
  Stage Shift (n/TST) 0.46 ± 0.19
  AHI 12.33 ± 26.33
    Mild: 5 < AHI > 15 n = 10 (16.12%)
    Moderate: 15 < AHI > 30 n = 8 (12.9%)
  Severe: AHI > 30 n = 11 (17.74%)
  PLMI 5.38 ± 11.8
    PLMI > 5 n = 5 (8.06%)
    PLMI > 15 n = 24 (38.7%)

Legend: AHI, Apnoea-Hypopnea Index; F, female; GDS, 15-item Geriatric Depression Scale; M, male; MDS-UPDRS-III, Movement Disorders Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale, motor section; MMSE, Mini Mental State Examination; PD, Parkinson’s Disease; PDSS-2, Parkinson’s Disease Sleep Scale; PLMI, Periodic Leg Movement Index; RBD, REM sleep behaviour disorder; REM, Rapid eyes movements; SE, Sleep Efficiency; SL, Sleep Latency; TST, Total sleep time; WASO, Wake After Sleep Onset